Report Detail

Pharma & Healthcare Global Cancer Biological Therapy Market Professional Survey Report 2019

  • RnM3751420
  • |
  • 16 September, 2019
  • |
  • Global
  • |
  • 113 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Biological therapy consists of using a living organism substance derived either from living organisms or laboratory produced variations of the substances to treat a particular disease. Biological therapies generally comprise interleukins, interferons, monoclonal antibodies, vaccines and so on. Biological therapy utilizes the body’s immune system either directly or indirectly in order to fight cancer. Some biological therapies for cancer use vaccines or bacteria to stimulate the body’s immune system to act against cancer cells where as some therapies involve antibodies.
North America dominates a major share of the global Cancer Biological Therapy market
On the other hand, Asia pacific is projected to develop at a highest rate owing to growingoccurrence of cancer, large patient pool, improving healthcare facilities, etc. 

The global Cancer Biological Therapy market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Cancer Biological Therapy volume and value at global level, regional level and company level. From a global perspective, this report represents overall Cancer Biological Therapy market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Cancer Biological Therapy in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Cancer Biological Therapy manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
ELI Lilly
Sanofi
Merck
Bayer
Roche
Novartis International
Pfizer
Bristol-Myers Squibb
Seattle Genetics
Amgen
Takeda Pharmaceuticals
GlaxoSmithKline
Spectrum Pharmaceuticals
Celgene Corporation
AstraZeneca, Plc.
Otsuka
Eisai
Abbvie
Incyte

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Monoclonal Antibodies
Vaccines
Cancer Growth Blockers
Blood Cell Growth Factors

Segment by Application
Hospitals
Diagnostic Laboratories
Research & Academic Laboratories
Pharmaceutical & Biotechnology Companies


Table of Contents

    Executive Summary

      1 Industry Overview of Cancer Biological Therapy

      • 1.1 Definition of Cancer Biological Therapy
      • 1.2 Cancer Biological Therapy Segment by Type
        • 1.2.1 Global Cancer Biological Therapy Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 Monoclonal Antibodies
        • 1.2.3 Vaccines
        • 1.2.4 Cancer Growth Blockers
        • 1.2.5 Blood Cell Growth Factors
      • 1.3 Cancer Biological Therapy Segment by Applications
        • 1.3.1 Global Cancer Biological Therapy Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Hospitals
        • 1.3.3 Diagnostic Laboratories
        • 1.3.4 Research & Academic Laboratories
        • 1.3.5 Pharmaceutical & Biotechnology Companies
      • 1.4 Global Cancer Biological Therapy Overall Market
        • 1.4.1 Global Cancer Biological Therapy Revenue (2014-2025)
        • 1.4.2 Global Cancer Biological Therapy Production (2014-2025)
        • 1.4.3 North America Cancer Biological Therapy Status and Prospect (2014-2025)
        • 1.4.4 Europe Cancer Biological Therapy Status and Prospect (2014-2025)
        • 1.4.5 China Cancer Biological Therapy Status and Prospect (2014-2025)
        • 1.4.6 Japan Cancer Biological Therapy Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Cancer Biological Therapy Status and Prospect (2014-2025)
        • 1.4.8 India Cancer Biological Therapy Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Cancer Biological Therapy
      • 2.3 Manufacturing Process Analysis of Cancer Biological Therapy
      • 2.4 Industry Chain Structure of Cancer Biological Therapy

      3 Development and Manufacturing Plants Analysis of Cancer Biological Therapy

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Cancer Biological Therapy Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Cancer Biological Therapy
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Cancer Biological Therapy Production and Capacity Analysis
      • 4.2 Cancer Biological Therapy Revenue Analysis
      • 4.3 Cancer Biological Therapy Price Analysis
      • 4.4 Market Concentration Degree

      5 Cancer Biological Therapy Regional Market Analysis

      • 5.1 Cancer Biological Therapy Production by Regions
        • 5.1.1 Global Cancer Biological Therapy Production by Regions
        • 5.1.2 Global Cancer Biological Therapy Revenue by Regions
      • 5.2 Cancer Biological Therapy Consumption by Regions
      • 5.3 North America Cancer Biological Therapy Market Analysis
        • 5.3.1 North America Cancer Biological Therapy Production
        • 5.3.2 North America Cancer Biological Therapy Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Cancer Biological Therapy Import and Export
      • 5.4 Europe Cancer Biological Therapy Market Analysis
        • 5.4.1 Europe Cancer Biological Therapy Production
        • 5.4.2 Europe Cancer Biological Therapy Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Cancer Biological Therapy Import and Export
      • 5.5 China Cancer Biological Therapy Market Analysis
        • 5.5.1 China Cancer Biological Therapy Production
        • 5.5.2 China Cancer Biological Therapy Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Cancer Biological Therapy Import and Export
      • 5.6 Japan Cancer Biological Therapy Market Analysis
        • 5.6.1 Japan Cancer Biological Therapy Production
        • 5.6.2 Japan Cancer Biological Therapy Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Cancer Biological Therapy Import and Export
      • 5.7 Southeast Asia Cancer Biological Therapy Market Analysis
        • 5.7.1 Southeast Asia Cancer Biological Therapy Production
        • 5.7.2 Southeast Asia Cancer Biological Therapy Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Cancer Biological Therapy Import and Export
      • 5.8 India Cancer Biological Therapy Market Analysis
        • 5.8.1 India Cancer Biological Therapy Production
        • 5.8.2 India Cancer Biological Therapy Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Cancer Biological Therapy Import and Export

      6 Cancer Biological Therapy Segment Market Analysis (by Type)

      • 6.1 Global Cancer Biological Therapy Production by Type
      • 6.2 Global Cancer Biological Therapy Revenue by Type
      • 6.3 Cancer Biological Therapy Price by Type

      7 Cancer Biological Therapy Segment Market Analysis (by Application)

      • 7.1 Global Cancer Biological Therapy Consumption by Application
      • 7.2 Global Cancer Biological Therapy Consumption Market Share by Application (2014-2019)

      8 Cancer Biological Therapy Major Manufacturers Analysis

      • 8.1 ELI Lilly
        • 8.1.1 ELI Lilly Cancer Biological Therapy Production Sites and Area Served
        • 8.1.2 ELI Lilly Product Introduction, Application and Specification
        • 8.1.3 ELI Lilly Cancer Biological Therapy Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 Sanofi
        • 8.2.1 Sanofi Cancer Biological Therapy Production Sites and Area Served
        • 8.2.2 Sanofi Product Introduction, Application and Specification
        • 8.2.3 Sanofi Cancer Biological Therapy Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 Merck
        • 8.3.1 Merck Cancer Biological Therapy Production Sites and Area Served
        • 8.3.2 Merck Product Introduction, Application and Specification
        • 8.3.3 Merck Cancer Biological Therapy Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Bayer
        • 8.4.1 Bayer Cancer Biological Therapy Production Sites and Area Served
        • 8.4.2 Bayer Product Introduction, Application and Specification
        • 8.4.3 Bayer Cancer Biological Therapy Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 Roche
        • 8.5.1 Roche Cancer Biological Therapy Production Sites and Area Served
        • 8.5.2 Roche Product Introduction, Application and Specification
        • 8.5.3 Roche Cancer Biological Therapy Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 Novartis International
        • 8.6.1 Novartis International Cancer Biological Therapy Production Sites and Area Served
        • 8.6.2 Novartis International Product Introduction, Application and Specification
        • 8.6.3 Novartis International Cancer Biological Therapy Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 Pfizer
        • 8.7.1 Pfizer Cancer Biological Therapy Production Sites and Area Served
        • 8.7.2 Pfizer Product Introduction, Application and Specification
        • 8.7.3 Pfizer Cancer Biological Therapy Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 Bristol-Myers Squibb
        • 8.8.1 Bristol-Myers Squibb Cancer Biological Therapy Production Sites and Area Served
        • 8.8.2 Bristol-Myers Squibb Product Introduction, Application and Specification
        • 8.8.3 Bristol-Myers Squibb Cancer Biological Therapy Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served
      • 8.9 Seattle Genetics
        • 8.9.1 Seattle Genetics Cancer Biological Therapy Production Sites and Area Served
        • 8.9.2 Seattle Genetics Product Introduction, Application and Specification
        • 8.9.3 Seattle Genetics Cancer Biological Therapy Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.9.4 Main Business and Markets Served
      • 8.10 Amgen
        • 8.10.1 Amgen Cancer Biological Therapy Production Sites and Area Served
        • 8.10.2 Amgen Product Introduction, Application and Specification
        • 8.10.3 Amgen Cancer Biological Therapy Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.10.4 Main Business and Markets Served
      • 8.11 Takeda Pharmaceuticals
      • 8.12 GlaxoSmithKline
      • 8.13 Spectrum Pharmaceuticals
      • 8.14 Celgene Corporation
      • 8.15 AstraZeneca, Plc.
      • 8.16 Otsuka
      • 8.17 Eisai
      • 8.18 Abbvie
      • 8.19 Incyte

      9 Development Trend of Analysis of Cancer Biological Therapy Market

      • 9.1 Global Cancer Biological Therapy Market Trend Analysis
        • 9.1.1 Global Cancer Biological Therapy Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Cancer Biological Therapy Regional Market Trend
        • 9.2.1 North America Cancer Biological Therapy Forecast 2019-2025
        • 9.2.2 Europe Cancer Biological Therapy Forecast 2019-2025
        • 9.2.3 China Cancer Biological Therapy Forecast 2019-2025
        • 9.2.4 Japan Cancer Biological Therapy Forecast 2019-2025
        • 9.2.5 Southeast Asia Cancer Biological Therapy Forecast 2019-2025
        • 9.2.6 India Cancer Biological Therapy Forecast 2019-2025
      • 9.3 Cancer Biological Therapy Market Trend (Product Type)
      • 9.4 Cancer Biological Therapy Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Cancer Biological Therapy Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Summary:
        Get latest Market Research Reports on Cancer Biological Therapy. Industry analysis & Market Report on Cancer Biological Therapy is a syndicated market report, published as Global Cancer Biological Therapy Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Cancer Biological Therapy market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

        Last updated on

        REPORT YOU MIGHT BE INTERESTED

        Purchase this Report

        $3,500.00
        $5,250.00
        $7,000.00
        2,772.00
        4,158.00
        5,544.00
        3,241.00
        4,861.50
        6,482.00
        529,725.00
        794,587.50
        1,059,450.00
        291,900.00
        437,850.00
        583,800.00
        Credit card Logo

        Related Reports


        Reason to Buy

        Request for Sample of this report